Humana (HUM) | Financial Analysis & Statements
Humana Inc. Large-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
32.5B
Net Income
-776.0M
-2.39%
Balance Sheet Metrics
Total Assets
48.9B
Total Liabilities
31.2B
Shareholders Equity
17.7B
Debt to Equity
1.76
Cash Flow Metrics
Operating Cash Flow
-2.1B
Free Cash Flow
-1.9B
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Humana Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 129.7B | 117.8B | 106.4B | 92.9B | 83.1B |
| Cost of Goods Sold | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | - | - | - | - | - |
| Other Operating Expenses | 15.9B | 13.9B | 13.3B | 12.7B | 9.6B |
| Total Operating Expenses | 15.9B | 13.9B | 13.3B | 12.7B | 9.6B |
| Operating Income | - | - | - | - | - |
| Operating Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 631.0M | 660.0M | 493.0M | 401.0M | 326.0M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 1.6B | 1.7B | 3.4B | 3.6B | 3.4B |
| Income Tax | 250.0M | 413.0M | 836.0M | 762.0M | 485.0M |
| Effective Tax Rate % | 16.1% | 24.0% | 24.7% | 21.4% | 14.5% |
| Net Income | 1.2B | 1.2B | 2.5B | 2.8B | 2.9B |
| Net Margin % | 0.9% | 1.0% | 2.3% | 3.0% | 3.5% |
| Key Metrics | |||||
| EBITDA | - | - | - | - | - |
| EPS (Basic) | $9.87 | $10.01 | $20.09 | $22.20 | $22.79 |
| EPS (Diluted) | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 |
| Basic Shares Outstanding | 120454000 | 120571000 | 123866000 | 126419000 | 128687998 |
| Diluted Shares Outstanding | 120454000 | 120571000 | 123866000 | 126419000 | 128687998 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Humana Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 4.2B | 2.2B | 4.7B | 5.1B | 3.4B |
| Short-term Investments | 15.7B | 18.2B | 16.6B | 13.9B | 13.2B |
| Accounts Receivable | 3.3B | 2.7B | 2.0B | 1.7B | 1.8B |
| Inventory | - | - | - | - | - |
| Other Current Assets | - | - | - | - | - |
| Total Current Assets | - | - | - | - | - |
| Non-Current Assets | |||||
| Property, Plant & Equipment | - | - | - | - | - |
| Goodwill | 20.5B | 20.7B | 20.8B | 20.0B | 24.8B |
| Intangible Assets | 1.1B | 1.4B | 1.7B | 1.8B | 2.6B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | - | - | - | - | - |
| Total Non-Current Assets | - | - | - | - | - |
| Total Assets | 48.9B | 46.5B | - | - | - |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 15.7B | 15.7B | 16.8B | 14.5B | 12.8B |
| Short-term Debt | 0 | 577.0M | 1.4B | 3.2B | 2.0B |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | - | - | - | - | - |
| Non-Current Liabilities | |||||
| Long-term Debt | 12.4B | 11.1B | 10.2B | 7.9B | 10.5B |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | - | - | - | - | - |
| Total Non-Current Liabilities | - | - | - | - | - |
| Total Liabilities | 31.2B | 30.0B | - | - | - |
| Equity | |||||
| Common Stock | 33.0M | 33.0M | 33.0M | 33.0M | 33.0M |
| Retained Earnings | 29.1B | 28.3B | 27.5B | 25.5B | 23.1B |
| Treasury Stock | 14.4B | 14.4B | 13.7B | 12.2B | 10.2B |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 17.7B | 16.4B | 16.3B | 15.4B | 16.1B |
| Key Metrics | |||||
| Total Debt | 12.4B | 11.7B | 11.7B | 11.1B | 12.5B |
| Working Capital | 0 | 0 | 0 | 0 | 0 |
Balance Sheet Composition
Humana Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 1.2B | 1.2B | 2.5B | 2.8B | 2.9B |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | 241.0M | 207.0M | 175.0M | 216.0M | 180.0M |
| Working Capital Changes | -1.8B | 154.0M | 81.0M | 534.0M | -556.0M |
| Operating Cash Flow | -278.0M | 1.5B | 2.7B | 3.5B | 2.6B |
| Investing Activities | |||||
| Capital Expenditures | -523.0M | -568.0M | -794.0M | -1.1B | -1.3B |
| Acquisitions | 34.0M | -89.0M | -233.0M | 2.4B | -4.2B |
| Investment Purchases | -6.4B | -8.2B | -7.6B | -6.0B | -7.2B |
| Investment Sales | 9.4B | 6.4B | 5.1B | 3.8B | 6.1B |
| Investing Cash Flow | 2.3B | -3.0B | -3.5B | -1.0B | -6.6B |
| Financing Activities | |||||
| Share Repurchases | -151.0M | -817.0M | -1.6B | -2.1B | -79.0M |
| Dividends Paid | -430.0M | -431.0M | -431.0M | -392.0M | -354.0M |
| Debt Issuance | 1.5B | 2.2B | 2.5B | 2.0B | 5.5B |
| Debt Repayment | -1.0B | -2.0B | -2.4B | -3.4B | -2.1B |
| Financing Cash Flow | -1.5B | -3.8B | -956.0M | -2.3B | 3.0B |
| Free Cash Flow | 375.0M | 2.4B | 3.0B | 3.4B | 920.0M |
| Net Change in Cash | 458.0M | -5.3B | -1.8B | 226.0M | -928.0M |
Cash Flow Trend
Humana Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
21.84
Forward P/E
14.19
Price to Book
1.47
Price to Sales
0.20
PEG Ratio
14.19
Profitability Ratios
Profit Margin
0.92%
Operating Margin
-1.79%
Return on Equity
7.04%
Return on Assets
4.30%
Financial Health
Current Ratio
2.00
Debt to Equity
74.82
Beta
0.44
Per Share Data
EPS (TTM)
$9.84
Book Value per Share
$146.42
Revenue per Share
$1,076.46
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| HUM | 25.8B | 21.84 | 1.47 | 7.04% | 0.92% | 74.82 |
| UnitedHealth | 322.3B | 26.81 | 3.42 | 12.18% | 2.68% | 73.98 |
| CVS Health | 101.1B | 55.65 | 1.31 | 2.29% | 0.44% | 106.06 |
| Elevance Health | 76.4B | 13.19 | 1.67 | 13.25% | 2.84% | 74.39 |
| Cigna | 72.7B | 12.61 | 1.77 | 15.13% | 2.17% | 75.14 |
| Centene | 20.2B | 8.06 | 1.01 | -28.68% | -3.79% | 90.56 |
Financial data is updated regularly. All figures are in the company's reporting currency.






